What it sells
Building AI therapeutics for physical health conditions like IBS.
Business model breakdown
Buyer: who owns the budget?
Health plans/payers (Medicare Advantage etc.) and referring providers; patients consume the app.
Trigger: what makes them buy now?
Avoidable GI specialist visits, imaging and ER use for IBS/functional GI; CMS ACCESS model contracting window.
Workflow: what inputs become what output?
Provider refers patient; patient follows 5-6 week app program (clinical hypnotherapy audio, pain reprocessing, breathing, CBT) for IBS (Nerva), pain (Relio), menopause (Evia), mental health (Claria).
Economics: what it saves and how it charges
Payer-paid digital therapeutic, offered 'at no upfront risk' to health plans; claims 71% pain reduction vs 35% active control in RCT.
Distribution: how it reaches customers
Referral by 20,000+ providers; B2B demo-led sales to health plans.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2019 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.